NYSE:BAX

Baxter International (BAX) Stock Forecast, Price & News

$37.54

+0.21 (+0.56%)

(As of 09/28/2023 ET)

Compare

Today's Range: $37.39
▼
$37.78
50-Day Range: $37.32
▼
$48.95
52-Week Range: $37.05
▼
$58.23

Volume: 4.07 million shs
Average Volume: 5.44 million shs
Market Capitalization: $19.01 billion

P/E Ratio: N/A
Dividend Yield: 3.09%
Price Target: $51.07

Baxter International MarketRank™ Forecast

Analyst Rating: Hold
2.21 Rating Score
Upside/Downside: 36.0% Upside
$51.07 Price Target
Short Interest: Healthy
1.46% of Float Sold Short
Dividend Strength: Moderate
Based on Four Factors
Sustainability: -1.95
Upright™ Environmental Score
News Sentiment: 0.70
Based on 7 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: 21.18%
From $2.55 to $3.09 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.69 out of 5 stars

Medical Sector

97th out of 969 stocks

Surgical & Medical Instruments Industry

16th out of 100 stocks

3.1

Analyst's Opinion

Consensus Rating
Baxter International has received a consensus rating of Hold. The company's average rating score is 2.21, and is based on 4 buy ratings, 9 hold ratings, and 1 sell rating.
Price Target Upside/Downside
According to analysts' consensus price target of $51.07, Baxter International has a forecasted upside of 36.0% from its current price of $37.54.
Amount of Analyst Coverage
Baxter International has only been the subject of 4 research reports in the past 90 days.

3.0

Short Interest

Percentage of Shares Shorted
1.46% of the float of Baxter International has been sold short.
Short Interest Ratio / Days to Cover
Baxter International has a short interest ratio ("days to cover") of 1.7, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Baxter International has recently increased by 2.23%, indicating that investor sentiment is decreasing.

2.5

Dividend Strength

Dividend Yield
Baxter International pays a meaningful dividend of 3.11%, higher than the bottom 25% of all stocks that pay dividends.
Dividend Growth
Baxter International has been increasing its dividend for 7 years.
Dividend Sustainability
Based on earnings estimates, Baxter International will have a dividend payout ratio of 37.54% next year. This indicates that Baxter International will be able to sustain or increase its dividend.

4.0

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
Baxter International has received a 55.71% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Vaccines (J07)", "Blood plasma proteins", and "Anaesthetics (N01)" products. See details.
Environmental Sustainability
The Environmental Impact score for Baxter International is -1.95.

2.6

News and Social Media Coverage

News Sentiment
Baxter International has a news sentiment score of 0.70. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
News Coverage This Week
MarketBeat has tracked 7 news articles for Baxter International this week, compared to 8 articles on an average week.
Search Interest
21 people have searched for BAX on MarketBeat in the last 30 days. This is an increase of 31% compared to the previous 30 days.
MarketBeat Follows
9 people have added Baxter International to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Baxter International insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 0.21% of the stock of Baxter International is held by insiders.
Percentage Held by Institutions
85.47% of the stock of Baxter International is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.9

Earnings and Valuation

Earnings Growth
Earnings for Baxter International are expected to grow by 21.18% in the coming year, from $2.55 to $3.09 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Baxter International is -6.63, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Baxter International is -6.63, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Growth Ratio
Baxter International has a PEG Ratio of 2.64. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Baxter International has a P/B Ratio of 3.21. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Baxter International (NYSE:BAX) Stock

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; premixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules; and a collaborative research agreement with Miromatrix Medical Inc. to develop treatments for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is based in Deerfield, Illinois.

BAX Price History

30 days | 90 days | 365 days | Advanced Chart

BAX Stock News Headlines

August 30, 2023 | marketbeat.com

A Significant Reversal is in Sight for These 5 Med Tech Companies (BAX)

Med tech stocks are down YOY despite strong secular tailwinds, cash flow, and dividends; the downturn in action is an opportunity and reversal is at hand.

August 29, 2023 | marketbeat.com

5 Good Reasons it's Time to Buy High-Yield Dividend King 3M (BAX)

3M settled the ear plug lawsuit, clearing the path forward. The stock offers investors a high yield and value that may be too hard to pass up

September 29, 2023 | Stansberry Research (Ad)

Experts: NVIDIA Now "Too Big to Succeed"

Several of the market’s top analysts are sounding the alarm that NVIDIA’s share price may have reached its breaking point.

September 26, 2023 | uk.finance.yahoo.com

Key Players Becton Dickinson (BD), Baxter, and ICU Medical Lead the Global Blood Transfusion Set Market to 2030

September 26, 2023 | msn.com

Rob Baxter highlights key lessons and positives from Exeter Chiefs' victory against Jersey Reds

September 26, 2023 | americanbankingnews.com

Baxter International Inc. (NYSE:BAX) Receives Consensus Recommendation of "Hold" from Brokerages

September 26, 2023 | americanbankingnews.com

Baxter International Inc. (NYSE:BAX) Receives $51.07 Average Target Price from Brokerages

September 21, 2023 | americanbankingnews.com

Reviewing Baxter International (NYSE:BAX) and BrainsWay (NASDAQ:BWAY)

September 29, 2023 | Behind the Markets (Ad)

Laser breakthrough could send stock soaring 2,467%

Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...

September 19, 2023 | finance.yahoo.com

Baxter to Host Third-Quarter 2023 Financial Results Conference Call for Investors

September 17, 2023 | msn.com

Emma Stone's Take on Bella Baxter in Poor Things Sheds Light on the Film's Controversial Sex Scenes

September 14, 2023 | finance.yahoo.com

Baxter takes 101-acre property off the market; to remain at Deerfield headquarters

September 14, 2023 | yahoo.com

eOne President Of International Distribution Stuart Baxter Exiting Ahead Of Lionsgate Sale Closure

September 13, 2023 | msn.com

Baxter Nixes Sale Of Campus, Opts To Stay In Deerfield: Spokesperson

September 12, 2023 | finance.yahoo.com

Reasons to Retain Baxter International (BAX) in Your Portfolio

September 12, 2023 | uk.style.yahoo.com

Scotland vs England: famous moments in ‘Auld Enemy’ fixtures from Kenny Dalglish to Jim Baxter - gallery

September 11, 2023 | benzinga.com

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Baxter International Inc. (BAX) Investors of a Class Action Lawsuit and Upcoming Deadline

September 9, 2023 | businesswire.com

BAXTER 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action ...

September 8, 2023 | benzinga.com

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Baxter International Inc. (BAX)

September 7, 2023 | yahoo.com

Express CEO Tim Baxter Sees ‘Extraordinary Opportunity’ in Denim

September 6, 2023 | msn.com

Deerfield Mayor Opposes Bridge's Rezoing Request At Baxter Property

September 5, 2023 | finance.yahoo.com

Infusion Pumps Global Market Forecast Report 2023-2028: Medtronic and Baxter International Innovate with FDA-Approved Infusion Systems Driving Growth

September 3, 2023 | msn.com

My first impressions about Nigeria — British Deputy High Commissioner Baxter

September 2, 2023 | stockhouse.com

EARLY SEPTEMBER FINAL DEADLINE: The Schall Law Firm Encourages Investors in Baxter International Inc. with Losses of $100,000 to Contact the Firm

September 2, 2023 | prnewswire.com

ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Baxter International Inc. Investors With Losses to Secure Counsel Before Important September 11 Deadline in Securities Class Action - BAX

August 31, 2023 | finance.yahoo.com

Is Baxter International (BAX) Too Good to Be True? A Comprehensive Analysis of a Potential ...

August 29, 2023 | finance.yahoo.com

Baxter to Present at Morgan Stanley 21st Annual Global Healthcare Conference

See More Headlines

Receive BAX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Baxter International and its competitors with MarketBeat's FREE daily newsletter.

BAX Company Calendar

Ex-Dividend for 7/3 Dividend: 6/01/2023
Dividend Payable: 7/03/2023
Last Earnings: 7/27/2023
Ex-Dividend for 10/2 Dividend: 8/31/2023
Today: 9/29/2023
Dividend Payable: 10/02/2023
Next Earnings (Confirmed): 11/02/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Surgical & medical instruments
Sub-Industry: Health Care Equipment
Sector: Medical
Current Symbol: NYSE:BAX
CUSIP: 07181310
CIK: 10456
Web: www.baxter.com
Phone: (224) 948-2000
Fax: 224-948-1813
Employees: 60,000
Year Founded: 1931

Price Target and Rating

Average Stock Price Forecast: $51.07
High Stock Price Forecast: $62.00
Low Stock Price Forecast: $43.00
Forecasted Upside/Downside: +36.0%
Consensus Rating: Hold
Rating Score (0-4): 2.21
Research Coverage: 14 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($5.66)
Trailing P/E Ratio: N/A
Forward P/E Ratio: 14.72
P/E Growth: 2.64
Net Income: $-2,433,000,000.00
Net Margins: -19.00%
Pretax Margin: -18.51%
Return on Equity: 24.94%
Return on Assets: 5.11%

Debt

Debt-to-Equity Ratio: 2.54
Current Ratio: 1.42
Quick Ratio: 0.92

Sales & Book Value

Annual Sales: $15.11 billion
Price / Sales: 1.26
Cash Flow: $12.64 per share
Price / Cash Flow: 2.97
Book Value: $11.69 per share
Price / Book: 3.21

Miscellaneous

Outstanding Shares: 506,400,000
Free Float: 505,342,000
Market Cap: $19.01 billion
Optionable: Optionable
Beta: 0.61

Social Links

7 Stocks to Buy And Hold Forever

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

Mr. Jose E. Almeida (Age 61)
Chairman, Pres & CEO
Comp: $2.1M

Mr. David S. Rosenbloom (Age 63)
Exec. VP & Gen. Counsel
Comp: $776.51k

Mr. Brian C. Stevens (Age 48)
Sr. VP, Interim CFO, Chief Accounting Officer & Controller

Mr. Talvis P. Love (Age 55)
Sr. VP & Chief Information Officer

Ms. Tobi Karchmer M.D.
M.S., Sr. VP and Chief Medical & Scientific Officer

Ms. Clare Trachtman
VP of Investor Relations

Ms. Stacey Eisen
Sr. VP of Global Communications

Ms. Jeanne K. Mason Ph.D. (Age 67)
?Exec. VP & Chief HR Officer

Mr. James W. Borzi (Age 60)
Exec. VP & Chief Supply Chain Officer

J. J. Markee
Chief Information Security Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

BAX Stock - Frequently Asked Questions

Should I buy or sell Baxter International stock right now?: 14 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Baxter International in the last twelve months. There are currently 1 sell rating, 9 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" BAX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BAX, but not buy additional shares or sell existing shares.
View BAX analyst ratings or view top-rated stocks.
What is Baxter International's stock price forecast for 2023?: 14 Wall Street research analysts have issued 12 month price targets for Baxter International's shares. Their BAX share price forecasts range from $43.00 to $62.00. On average, they expect the company's stock price to reach $51.07 in the next twelve months. This suggests a possible upside of 36.0% from the stock's current price.
View analysts price targets for BAX or view top-rated stocks among Wall Street analysts.
How have BAX shares performed in 2023?: Baxter International's stock was trading at $50.97 at the start of the year. Since then, BAX stock has decreased by 26.3% and is now trading at $37.54.
View the best growth stocks for 2023 here.
Are investors shorting Baxter International?: Baxter International saw a increase in short interest in August. As of August 31st, there was short interest totaling 7,170,000 shares, an increase of 10.8% from the August 15th total of 6,470,000 shares. Based on an average daily trading volume, of 4,580,000 shares, the days-to-cover ratio is currently 1.6 days. Approximately 1.4% of the shares of the company are short sold.
View Baxter International's Short Interest.
When is Baxter International's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, November 2nd 2023.
View our BAX earnings forecast.
How can I listen to Baxter International's earnings call?: Baxter International will be holding an earnings conference call on Thursday, November 2nd at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link.
How were Baxter International's earnings last quarter?: Baxter International Inc. (NYSE:BAX) announced its quarterly earnings results on Thursday, July, 27th. The medical instruments supplier reported $0.55 earnings per share for the quarter, missing analysts' consensus estimates of $0.59 by $0.04. The medical instruments supplier had revenue of $3.71 billion for the quarter, compared to analysts' expectations of $3.79 billion. Baxter International had a negative net margin of 19.00% and a positive trailing twelve-month return on equity of 24.94%.
How often does Baxter International pay dividends? What is the dividend yield for Baxter International?: Baxter International announced a quarterly dividend on Tuesday, July 18th. Investors of record on Friday, September 1st will be paid a dividend of $0.29 per share on Monday, October 2nd. This represents a $1.16 annualized dividend and a dividend yield of 3.09%. The ex-dividend date of this dividend is Thursday, August 31st.
Read our dividend analysis for BAX.
What ETFs hold Baxter International's stock?: ETFs with the largest weight of Baxter International (NYSE:BAX) stock in their portfolio include Simplify Health Care ETF (PINK), BTD Capital Fund (DIP), First Trust Indxx Medical Devices ETF (MDEV), iShares U.S. Medical Devices ETF (IHI), BlackRock Large Cap Value ETF (BLCV), Invesco Zacks Mid-Cap ETF (CZA), Invesco S&P 500 Equal Weight Health Care ETF (RYH) and SPDR S&P Health Care Equipment ETF (XHE).
Is Baxter International a good dividend stock?: Baxter International (NYSE:BAX) pays an annual dividend of $1.16 per share and currently has a dividend yield of 3.11%.
Read our dividend analysis for BAX.

What guidance has Baxter International issued on next quarter's earnings?: Baxter International issued an update on its third quarter 2023 earnings guidance on Thursday, July, 27th. The company provided earnings per share guidance of $0.65-$0.67 for the period, compared to the consensus estimate of $0.80. The company issued revenue guidance of -.
What is José (Joe) Almeida's approval rating as Baxter International's CEO?: 506 employees have rated Baxter International Chief Executive Officer José (Joe) Almeida on Glassdoor.com. José (Joe) Almeida has an approval rating of 85% among the company's employees.
What other stocks do shareholders of Baxter International own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Baxter International investors own include CA (CA), Johnson & Johnson (JNJ), Pfizer (PFE), Cisco Systems (CSCO), Intel (INTC), Abbott Laboratories (ABT), Procter & Gamble (PG), AT&T (T) and Verizon Communications (VZ).
What is Baxter International's stock symbol?: Baxter International trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAX."
How do I buy shares of Baxter International?: Shares of BAX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Baxter International's stock price today?: One share of BAX stock can currently be purchased for approximately $37.54.
How much money does Baxter International make?: Baxter International (NYSE:BAX) has a market capitalization of $19.01 billion and generates $15.11 billion in revenue each year. The medical instruments supplier earns $-2,433,000,000.00 in net income (profit) each year or ($5.66) on an earnings per share basis.
How many employees does Baxter International have?: The company employs 60,000 workers across the globe.
Does Baxter International have any subsidiaries?: The following companies are subsidiares of Baxter International: ApaTech Limited, Baxter (China) Investment Co. Ltd, Baxter (Hellas) EPE, Baxter (India) Private Limited, Baxter AO, Baxter Belgium SPRL, Baxter Company Ltd, Baxter Corporation (Canada), Baxter Corporation Englewood, Baxter Deutschland GmbH, Baxter Distribution Center Europe SA, Baxter Healthcare (Guangzhou) Company Ltd, Baxter Healthcare (Shanghai) Company Ltd., Baxter Healthcare (Suzhou) Company Ltd, Baxter Healthcare (Thailand) Company Limited, Baxter Healthcare (Tianjin) Co. Ltd., Baxter Healthcare Corporation, Baxter Healthcare Limited, Baxter Healthcare Limited (Hong Kong China), Baxter Healthcare Limited (Taiwan), Baxter Healthcare Pty Ltd, Baxter Healthcare SA, Baxter Healthcare SA (Singapore Woodlands Branch), Baxter Healthcare Trading (Shanghai) Co. Ltd., Baxter Holding B.V., Baxter Hospitalar Ltda., Baxter Incorporated, Baxter Innovations & Business Solutions Private Limited (India), Baxter Limited, Baxter Manufacturing (Thailand) Co. Ltd., Baxter Medical AB, Baxter Oncology GmbH, Baxter Pharmaceutical Solutions LLC, Baxter Pharmaceuticals (Asia) Pte Ltd., Baxter Pharmaceuticals India Pvt Ltd., Baxter Polska Sp. z o.o., Baxter Productos Medicos Ltda., Baxter R and D Europe SPRL, Baxter S.A. de C.V., Baxter S.A.S., Baxter S.L., Baxter S.p.A., Baxter SA, Baxter Sales and Distribution LLC, Baxter Services Europe SA, Baxter Shared Services & Competencies Limited, Baxter de Guatemala Sociedad Anonima, Bieffe Medital S.p.A., Cheetah Medical, Cheetah Medical (Israel) Ltd., Cheetah Medical (UK) Limited, Cheetah Medical Inc., Gambro AB, Gambro Dasco S.p.A., Gambro Dialysatoren GmbH, Gambro Industries SAS, Gambro Lundia AB, Gambro Renal Products Inc., Laboratorios Baxter S.A., RTS Colombia SAS, Synovis Life Technologies Inc., and Synovis Micro Companies Alliance Inc..
Read More
How can I contact Baxter International?: Baxter International's mailing address is One Baxter Parkway DF2-1W, Deerfield IL, 60015. The official website for the company is www.baxter.com. The medical instruments supplier can be reached via phone at (224) 948-2000, via email at global_corp_investor_relations@baxter.com, or via fax at 224-948-1813.

This page (NYSE:BAX) was last updated on 9/29/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial